Form 8-K - Current report:
SEC Accession No. 0001387131-21-001947
Filing Date
2021-02-09
Accepted
2021-02-09 16:35:00
Documents
12
Period of Report
2021-02-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_020921.htm   iXBRL 8-K 25263
  Complete submission text file 0001387131-21-001947.txt   199379

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20210209.xsd EX-101.SCH 3226
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20210209_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20210209_pre.xml EX-101.PRE 22737
5 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_020921_htm.xml XML 3595
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 21607023
SIC: 2834 Pharmaceutical Preparations